INVEX Therapeutics Ltd (IXC) — Financial Flexibility Index
INVEX Therapeutics Ltd (IXC) has a Financial Flexibility Index of -4.42x as of December 2025. Free cash flow of AU$-779.73K (operating CF AU$-779.73K minus capex AU$0.00) represents -4% of total liabilities (AU$176.49K). Also explore INVEX Therapeutics Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
INVEX Therapeutics Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for INVEX Therapeutics Ltd across 7 annual periods. See INVEX Therapeutics Ltd (IXC) net asset quality to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for INVEX Therapeutics Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for INVEX Therapeutics Ltd. For the full company profile including market capitalisation, see market value of INVEX Therapeutics Ltd.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.96x | AU$-652.57K | AU$-652.57K | AU$220.59K | ▲ +47.8% |
| 2024 | -5.66x | AU$-2.44 Million | AU$-2.44 Million | AU$431.63K | ▼ -29.6% |
| 2023 | -4.37x | AU$-6.87 Million | AU$-6.87 Million | AU$1.57 Million | ▼ -29.9% |
| 2022 | -3.36x | AU$-3.38 Million | AU$-3.38 Million | AU$1.00 Million | ▼ -32.0% |
| 2021 | -2.55x | AU$-1.68 Million | AU$-1.68 Million | AU$658.61K | ▼ -220.3% |
| 2020 | -0.80x | AU$-1.60 Million | AU$-1.60 Million | AU$2.02 Million | ▼ -235.3% |
| 2019 | -0.24x | AU$-221.94K | AU$-230.13K | AU$935.49K | — |